Glycosyn Inc is categorized under Commercial Biotechnical Research in Medford, MA and active since 2002.
Glycosyn Inc was established in 2002, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Howard M Newburg at the company’s single location by writing to 196 Boston Avenue # 1200, Medford, Massachusetts MA 02155 or by phoning (781) 393-9009. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Glycosyn Inc |
| Contact Person: | Howard M Newburg |
| Address: | 196 Boston Avenue # 1200, Medford, Massachusetts 02155 |
| Phone Number: | (781) 393-9009 |
| Website Address: | glycosyninc.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Glycosyn Inc was started in 2002 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Howard M Newburg for inquiries that concern Glycosyn Inc by calling the company number (781) 393-9009, as your correspondence is most welcome. Additionally, the physical location of the single location of Glycosyn Inc can be found at the coordinates 42.415629,-71.127627 as well as the street address 196 Boston Avenue # 1200 in Medford, Massachusetts 02155.
For its online presence, you may visit Glycosyn Inc’s website at glycosyninc.com and engage with its social media outlets through on Twitter and on Facebook.